Please assess the completion status of the following clinical trial:

Trial Title: Study of DERMABOND ProPen in Closure of Colectomy Wounds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing elective colectomies for benign or malignant conditions~* Midline vertical incisions or skin crease incisions~* Above the age of 21 years old~* Able to make own valid informed decisions~Exclusion Criteria:~* Patients undergoing surgery for recurrent or metastatic disease~* Surgery for surgical emergencies such as acute abdomen or bleeding~* Known allergy to DERMABOND ProPen Tissue Adhesive or any of its constituents (cyanoacrylate or formaldehyde)~* Patients on immunosuppression

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Skin Staples (Type: ACTIVE_COMPARATOR): Skin closure with skin staples
- Dermabond (Type: EXPERIMENTAL): Closure of abdominal wound with dermabond (2-octylcyanoacrylate)

Based on this trial design, predict the completion outcome and termination type (if applicable).